# The Use of Furosemide in Patients on Dialysis

> **NCT01815892** · PHASE4 · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 51 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Withdrawal of furosemide
- **DRUG:** furosemide administration

## Key facts

- **NCT ID:** NCT01815892
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01815892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01815892, "The Use of Furosemide in Patients on Dialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01815892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*